The store will not work correctly when cookies are disabled.
5-(3-tert-Butyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA419472
PubChem CID: 11779704
Max Phase: Preclinical
Molecular Formula: C21H22N2
Molecular Weight: 302.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1cccc(C2=Cc3ccccc3C3=NCCN23)c1
Standard InChI: InChI=1S/C21H22N2/c1-21(2,3)17-9-6-8-16(13-17)19-14-15-7-4-5-10-18(15)20-22-11-12-23(19)20/h4-10,13-14H,11-12H2,1-3H3
Standard InChI Key: GVSJNEVJDKYMFT-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
2.6167 -3.0375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1000 -3.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6500 -2.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -2.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5875 -3.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1000 -3.9417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6042 -2.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2500 -2.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5417 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1417 -2.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -3.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -3.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -3.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5417 -1.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0542 -3.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0917 -2.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -2.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1375 -1.9292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1417 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0417 -3.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7417 -4.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5417 -2.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5542 -2.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 9 1 0
11 10 1 0
12 1 1 0
13 12 1 0
14 8 1 0
15 5 1 0
16 7 1 0
17 18 1 0
18 14 2 0
19 11 1 0
20 11 1 0
21 11 1 0
22 15 2 0
23 16 2 0
6 13 1 0
5 7 2 0
10 17 2 0
23 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.42 | Molecular Weight (Monoisotopic): 302.1783 | AlogP: 4.56 | #Rotatable Bonds: 1 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.13 | CX LogP: 4.61 | CX LogD: 4.42 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.50 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |